RecruitingPhase 3NCT05879926Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Sponsor: NRG OncologyAvon, IN · Carmel, IN · Crown Point, IN · +1223 more sites
RecruitingPhase 3NCT05812807Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabSponsor: Alliance for Clinical Trials in OncologyAvon, IN · Carmel, IN · Crown Point, IN · +825 more sites
RecruitingPhase not listedNCT06551116QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerSponsor: Abramson Cancer Center at Penn MedicineCrown Point, IN · +36 more sites
RecruitingPhase 1NCT04389632A Study of Sigvotatug Vedotin in Advanced Solid TumorsSponsor: Seagen, a wholly owned subsidiary of PfizerCrown Point, IN · Fort Wayne, IN · Indianapolis, IN · +103 more sites
RecruitingPhase 3NCT04852887De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Sponsor: NRG OncologyAvon, IN · Carmel, IN · Crown Point, IN · +809 more sites
RecruitingPhase 3NCT05929768Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerSponsor: SWOG Cancer Research NetworkAvon, IN · Carmel, IN · Crown Point, IN · +952 more sites